Literature DB >> 9420231

Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus.

L Yuan1, S Y Kang, L A Ward, T L To, L J Saif.   

Abstract

Newborn gnotobiotic pigs were inoculated twice perorally (p.o.) (group 1) or intramuscularly (i.m.) (group 2) or three times i.m. (group 3) with inactivated Wa strain human rotavirus and challenged with virulent Wa human rotavirus 20 to 24 days later. To assess correlates of protection, antibody-secreting cells (ASC) were enumerated in intestinal and systemic lymphoid tissues from pigs in each group at selected postinoculation days (PID) or postchallenge days. Few virus-specific ASC were detected in any tissues of group 1 pigs prior to challenge. By comparison, groups 2 and 3 had significantly greater numbers of virus-specific immunoglobulin M (IgM) ASC in intestinal and splenic tissues at PID 8 and significantly greater numbers of virus-specific IgG ASC and IgG memory B cells in spleen and blood at challenge. However, as for group 1, few virus-specific IgA ASC or IgA memory B cells were detected in any tissues of group 2 and 3 pigs. Neither p.o. nor i.m. inoculation conferred significant protection against virulent Wa rotavirus challenge (0 to 6% protection rate), and all groups showed significant anamnestic virus-specific IgG and IgA ASC responses. Hence, high numbers of IgG ASC or memory IgG ASC in the systemic lymphoid tissues at the time of challenge did not correlate with protection. Further, our findings suggest that inactivated Wa human rotavirus administered either p.o. or parenterally is significantly less effective in inducing intestinal IgA ASC responses and conferring protective immunity than live Wa human rotavirus inoculated orally, as reported earlier (L. Yuan, L. A. Ward, B. I. Rosen, T. L. To, and L. J. Saif, J. Virol. 70:3075-3083, 1996). Thus, more efficient mucosal delivery systems and rotavirus vaccination strategies are needed to induce intestinal IgA ASC responses, identified previously as a correlate of protective immunity to rotavirus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420231      PMCID: PMC109380          DOI: 10.1128/JVI.72.1.330-338.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Developmental immunity in the piglet.

Authors:  Y B Kim
Journal:  Birth Defects Orig Artic Ser       Date:  1975

2.  Diarrhoea in mice infected with a human rotavirus.

Authors:  V S Gouvea; A A Alencar; O M Barth; L de Castro; A M Fialho; H P Araújo; S Majerowicz; H G Pereira
Journal:  J Gen Virol       Date:  1986-03       Impact factor: 3.891

3.  Minimal infective dose of rotavirus.

Authors:  D Y Graham; G R Dufour; M K Estes
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

Review 4.  Human viral gastroenteritis.

Authors:  G Cukor; N R Blacklow
Journal:  Microbiol Rev       Date:  1984-06

5.  Porcine pararotavirus: detection, differentiation from rotavirus, and pathogenesis in gnotobiotic pigs.

Authors:  E H Bohl; L J Saif; K W Theil; A G Agnes; R F Cross
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

6.  Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge.

Authors:  G Zissis; J P Lambert; P Marbehant; D Marissens; M Lobmann; P Charlier; A Delem; N Zygraich
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

7.  Ethylenimine-inactivated rabies vaccine of tissue culture origin.

Authors:  O P Larghi; V L Savy; A E Nebel; A Rodriguez
Journal:  J Clin Microbiol       Date:  1976-01       Impact factor: 5.948

8.  Human rotavirus type 2: cultivation in vitro.

Authors:  R G Wyatt; W D James; E H Bohl; K W Theil; L J Saif; A R Kalica; H B Greenberg; A Z Kapikian; R M Chanock
Journal:  Science       Date:  1980-01-11       Impact factor: 47.728

9.  Rabbit model of rotavirus infection.

Authors:  M E Conner; M K Estes; D Y Graham
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

10.  Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody.

Authors:  R L Ward; M M McNeal; J F Sheridan
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

View more
  46 in total

Review 1.  Immune responses to rotavirus infection and vaccination and associated correlates of protection.

Authors:  Ulrich Desselberger; Hans-Iko Huppertz
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Antibody-secreting cell responses to rotavirus proteins in gnotobiotic pigs inoculated with attenuated or virulent human rotavirus.

Authors:  K O Chang; O H Vandal; L Yuan; D C Hodgins; L J Saif
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  Quantification of proliferating lymphocyte subsets appearing in the intestinal lymph and the blood.

Authors:  K H Thielke; R Pabst; H J Rothkötter
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

4.  Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.

Authors:  Anastasia N Vlasova; Lulu Shao; Sukumar Kandasamy; David D Fischer; Abdul Rauf; Stephanie N Langel; Kuldeep S Chattha; Anand Kumar; Huang-Chi Huang; Gireesh Rajashekara; Linda J Saif
Journal:  Eur J Immunol       Date:  2016-08-11       Impact factor: 5.532

5.  Effects of maternal antibodies on protection and development of antibody responses to human rotavirus in gnotobiotic pigs.

Authors:  D C Hodgins; S Y Kang; L deArriba; V Parreño; L A Ward; L Yuan; T To; L J Saif
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

Authors:  A M González; T V Nguyen; M S P Azevedo; K Jeong; F Agarib; C Iosef; K Chang; K Lovgren-Bengtsson; B Morein; L J Saif
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

7.  Dietary rice bran protects against rotavirus diarrhea and promotes Th1-type immune responses to human rotavirus vaccine in gnotobiotic pigs.

Authors:  Xingdong Yang; Ke Wen; Christine Tin; Guohua Li; Haifeng Wang; Jacob Kocher; Kevin Pelzer; Elizabeth Ryan; Lijuan Yuan
Journal:  Clin Vaccine Immunol       Date:  2014-07-30

8.  Development of a human rotavirus induced diarrhea model in Chinese mini-pigs.

Authors:  Jin-Tao Li; Jing Wei; Hong-Xia Guo; Jiang-Bo Han; Nan Ye; Hai-Yang He; Tian-Tian Yu; Yu-Zhang Wu
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

9.  Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs.

Authors:  Wei Zhang; Marli S P Azevedo; Ke Wen; Ana Gonzalez; Linda J Saif; Guohua Li; Ahmed E Yousef; Lijuan Yuan
Journal:  Vaccine       Date:  2008-05-19       Impact factor: 3.641

10.  Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.

Authors:  Marli S P Azevedo; Lijuan Yuan; Cristiana Iosef; Kyeong-Ok Chang; Yunjeong Kim; Trang Van Nguyen; Linda J Saif
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.